Skip Nav Destination
Article navigation
Case Reports|
October 1989
Oral Transmucosal Fentanyl Citrate for the Treatment of Breakthrough Cancer Pain: A Case Report
MICHAEL A. ASHBURN, M.D.;
MICHAEL A. ASHBURN, M.D.
*Assistant Professor.
Search for other works by this author on:
PERRY G. FINE, M.D.;
PERRY G. FINE, M.D.
†Assistant Professor; stockholder, Anesta Corporation.
Search for other works by this author on:
THEODORE H. STANLEY, M.D.
THEODORE H. STANLEY, M.D.
‡Professor; stockholder, Chairman of Scientific Advisory Board, and Chairman of the Board of Directors of Anesta Corporation.
Search for other works by this author on:
Anesthesiology October 1989, Vol. 71, 615–617.
Citation
MICHAEL A. ASHBURN, PERRY G. FINE, THEODORE H. STANLEY; Oral Transmucosal Fentanyl Citrate for the Treatment of Breakthrough Cancer Pain: A Case Report. Anesthesiology 1989; 71:615–617 doi: https://doi.org/10.1097/00000542-198910000-00026
Download citation file:
Citing articles via
Most Viewed
Related Articles
Influence of Age on the Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Fentanyl Citrate
Anesthesiology (September 2004)
Influence of Hepatic and Intestinal Cytochrome P4503A Activity on the Acute Disposition and Effects of Oral Transmucosal Fentanyl Citrate
Anesthesiology (September 2004)
Multiple Dose Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers
Anesthesiology (March 2000)
A Comparison of Change in the 0–10 Numeric Rating Scale to a Pain Relief Scale and Global Medication Performance Scale in a Short-term Clinical Trial of Breakthrough Pain Intensity
Anesthesiology (June 2010)
Dose Proportionality and Pharmacokinetics of Oral Transmucosal Fentanyl Citrate
Anesthesiology (February 1998)
